AUTONOMIX MEDICAL, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
AUTONOMIX MEDICAL, INC. (AMIX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.20 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-05-27
- AUTONOMIX MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2026 was $2.20M, a 4.35% decline from fiscal 2025.
- AUTONOMIX MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.30M, a 21.05% increase from fiscal 2024.
- AUTONOMIX MEDICAL, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $1.90M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2026-03-31 | $2.20M 10-K · filed 2026-05-27 |
| 2025-03-31 | $2.30M 10-K · filed 2025-05-29 |
| 2024-03-31 | $1.90M 10-K · filed 2024-05-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |